Salud financiera de hoja de balance de Surmodics
Salud financiera controles de criterios 5/6
Surmodics tiene un patrimonio de accionistas total de $124.0M y una deuda total de $29.5M, lo que sitúa su ratio deuda-patrimonio en 23.8%. Sus activos y pasivos totales son $182.8M y $58.9M respectivamente. El BAIT de Surmodics es de $18.5M, por lo que su ratio de cobertura de intereses es de 10.1. Tiene efectivo e inversiones a corto plazo que ascienden a $40.9M.
Información clave
23.8%
Ratio deuda-patrimonio
US$29.48m
Deuda
| Ratio de cobertura de intereses | 10.1x |
| Efectivo | US$40.94m |
| Patrimonio | US$123.95m |
| Total pasivo | US$58.86m |
| Activos totales | US$182.81m |
Actualizaciones recientes sobre salud financiera
We Think Surmodics (NASDAQ:SRDX) Can Stay On Top Of Its Debt
Sep 17
Is Surmodics (NASDAQ:SRDX) A Risky Investment?
May 14Surmodics (NASDAQ:SRDX) Has Debt But No Earnings; Should You Worry?
Jan 08Recent updates
There's Reason For Concern Over Surmodics, Inc.'s (NASDAQ:SRDX) Massive 29% Price Jump
Jun 06Is Now The Time To Look At Buying Surmodics, Inc. (NASDAQ:SRDX)?
May 30Surmodics (NASDAQ:SRDX) Is Experiencing Growth In Returns On Capital
May 02We Think Surmodics (NASDAQ:SRDX) Can Stay On Top Of Its Debt
Sep 17News Flash: Analysts Just Made A Notable Upgrade To Their Surmodics, Inc. (NASDAQ:SRDX) Forecasts
Jun 26An Intrinsic Calculation For Surmodics, Inc. (NASDAQ:SRDX) Suggests It's 27% Undervalued
Jun 22Is Surmodics (NASDAQ:SRDX) A Risky Investment?
May 14Market Participants Recognise Surmodics, Inc.'s (NASDAQ:SRDX) Revenues Pushing Shares 36% Higher
Apr 17Shareholders May Be Wary Of Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation Package
Feb 03Surmodics (NASDAQ:SRDX) Has Debt But No Earnings; Should You Worry?
Jan 08Surmodics gets additional $125M in credit facility
Oct 17Surmodics Non-GAAP EPS of -$0.34 beats by $0.04, revenue of $24.9M misses by $0.29M
Jul 27Estimating The Intrinsic Value Of Surmodics, Inc. (NASDAQ:SRDX)
Jul 22Is It Too Late To Consider Buying Surmodics, Inc. (NASDAQ:SRDX)?
May 03Shareholders May Not Be So Generous With Surmodics, Inc.'s (NASDAQ:SRDX) CEO Compensation And Here's Why
Feb 04Do Surmodics's (NASDAQ:SRDX) Earnings Warrant Your Attention?
Dec 24Estimating The Fair Value Of Surmodics, Inc. (NASDAQ:SRDX)
Aug 13When Should You Buy Surmodics, Inc. (NASDAQ:SRDX)?
Jun 09Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($84.3M) de SRDX superan a sus pasivos a corto plazo ($19.2M).
Pasivo a largo plazo: Los activos a corto plazo de SRDX ($84.3M) superan a sus pasivos a largo plazo ($39.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: SRDX tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de SRDX ha crecido de 0% a 23.8% en los últimos 5 años.
Cobertura de la deuda: La deuda de SRDX está bien cubierta por el flujo de caja operativo (87.4%).
Cobertura de intereses: Los pagos de intereses de la deuda de SRDX están bien cubiertos por el BAIT (10.1x cobertura).